🌱 KidneyEnergy.com

← brief for 2026-08-10 · Slowing decline

SGLT2 Inhibitor Use in Type 2 Diabetes in England: A Population-Based Cross-Sectional Study of Uptake of NICE Guidance.

Article C Peer reviewed Observational

Key takeaways

This study looked at how widely SGLT2 inhibitors — diabetes drugs that also protect the kidneys — are actually being prescribed in England, compared with official guidance. It found gaps in uptake. It describes prescribing patterns at one point in time, not treatment effects.

Who did this work

Muller P · Wray J · Rahman M · Hawkins J · Bakhai C · Cuthbertson DJ · Willans R · Yelland E · Rowark S · Watras M · Sheridan Rains L · Adler AI

Source

Journal article · PubMed — the drug frontier · 2026 Aug 4
https://pubmed.ncbi.nlm.nih.gov/42552240/